drugset / Trial / NCT03862287

Incidence of TNS After Intrathecal Lidocaine v.s Bupivacaine

NCT03862287 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will look into the incidence of Transient neurological symptoms (TNS) after the intrathecal use of lidocaine in comparison to intrathecal Bupivacaine.

Timeline

Start
2018-11-01
Primary completion
2019-12
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 6 mg Other
Comparator Lidocaine Other / unclassified 60 mg Other